Valion Bio (VBIO) Other Non-Current Assets (2021 - 2026)

Valion Bio has reported Other Non-Current Assets for 6 years, with the latest figure at $631000.0 in Q2 2026.

• On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $631000.0 in Q2 2026; TTM through Jun 2026 was $631000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $136000.0, down 65.74% from the prior year.
• Other Non-Current Assets was $631000.0 for Q2 2026 at Valion Bio, up from $136000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $631000.0 in Q2 2026, with the low at $2000.0 in Q1 2025.
• Average Other Non-Current Assets over 5 years is $163133.3, with a median of $65000.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets surged 1091.84% in 2022, then tumbled 96.72% in 2025.
• Over 5 years, Other Non-Current Assets stood at $584000.0 in 2022, then plunged by 94.18% to $34000.0 in 2023, then surged by 1067.65% to $397000.0 in 2024, then slumped by 65.74% to $136000.0 in 2025, then jumped by 363.97% to $631000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $631000.0 (Q2 2026), $136000.0 (Q4 2025), and $211000.0 (Q3 2025), per Business Quant data.